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Results among rlom.?l children were cowed by u!-ired Student ttest. There was no statistical-difference between IGFBP-3 and DHEA-S in males and females wnereas 1GF-1 levels ln Tanner h r t a l stages I to I11 were sirniflcantly higher in females. IGFBP-5 was normal in the 7 patlents wlth short stature low m 60% of patlents with GX deficiency,, 25% of whi,ch had low ibF-1 compared to contrcls. The 3 patlents wlth precocious pmerty had normal IGFBP-3 levels for pubertal stage.
SER'J?I IGF-1 AW IGF-EIFDIMG PXOTEIN-3 LEIBLS BEFORE Ah9 AFTER RBAL TP$fiSPLiLTATI@N (TX ) .
P3$.%alinii
T.,. Fainstein-Day, P., Gdtman, R., Ferraris, J. kDartments of Pediatrics a?d Endocrinoloav. Italian Hos~ltal.
Fallure of -oiGA-is-frequent in parlents (P) wlth end stage renal disease (ESRD) and after renal TX. We studied serum IFF-1 and IGFbindlna motein-3 (IGFEP-3) levels (RIA) in 18 ESRD P on dialvsis 8.0-29:5-yezs old (x:18.1), and ih 19 TX P 4.7-21.8 years-old (x:12.9). ESRD P had lower m e w IGF-1 levels (xtsd:0.66+0.25 U/ml) than TX P (1.77-0.89 U/ml, p < 3.001). In contrast, mean IGF3P-3 was hiaher in ZSRD P l8. IGF-1 levels correlated with height SDS for chronological age in ESRD (r:0.63) and in TX P (r:0.67). In TX P, there was a significant correlation between IGFBP-3 a d IGF-1 levels (r:0.53),..and between IGFBI-3 aqd Tanner staoe 1 r : 0.56 ) . We conclude that' increased levels of IGFBP-3 may be implicated ln IGF inhibition. The physiologic elevation of IGF-1 levels during p a r t y was observed in TX P but not in ESRD P.
Semiyez. C., Beas, F., Ugarte, F., IRiguez, G. IDIMI, Universlt; cf Chile. Santiaoo. Chile. We studied the hor.&nal levels of newbor~s, during the third day of life in 47 SGA infmts with a mean welght of 2.29 kgs. and mem lenah of 45.5 cms, anc? in 40 controls AGA infants wirh a mean weisht of 3.37 kgs. atd mean length of 49.1 cms. There were no sigr.ific&?t differences between SGA and AGA newborns ln the serum concentrations of Insulin: 4525.4 vs 4024.1 uUI/ml; Prolactin: 184t38 vs 162.8t51 ng/el: T4: 13.1t3 vs 15.3~2.5 uaidl: T3: 143t47 vs 15lt42 ncldl; ~esfosterone: 1.611.5 vs 1.2t1.1 i;a/mi and Estradiol: 495tt18:l vs 501t23.4 m/ml respectively, but there was a significant difference in IGF-I a?d IGF-I1 levels. In a prevlous study, usmg PCR followed by restriction e.nzpe or SSCP analysis, we identified the genetic lesion in 50 % of the alleles ii the salt/losing (SL) form, but i n none of the alleles in tine simple virilizing (SV) form. In this study we have added a dotblot technique using specific oligonucleotides in order to evaluate the most frequently described mutations in American and Emopean populations. A total of 18 affected families were studied, (12 SL and 6 SV). Four different regions of the CF21B gene were amplified by aze correlated with newborn size. The higher plasma levels observed a?d also in Group IIA had a bone mass within the normal limits. In on the third day of life in SGA ixfants may signal the hgirning of Group IIB, all subjects had a bone mass below -2 standard copnsator( rechanisms of post natal growth iii these children.
deviations, (except for one case with a Z score of -0.49). We conclude that most patients with androgen insensitiviry who were castrated after puberty, and all subjects wlth various caEses of male pseudohermaphroditism who were castrated in childhood and started on estrogen before the age of 12, had normal bone mss. The preGence of endogenocs or exogenous estrogen at the time of puberty ap-pears to be i m r t w t for the mainte~ance of normal bone mass.
